Cannabis

Cannabis
By Aimee Gould Shunney, ND

Given the exponential increase in use, and emerging research on the effective application of cannabidiol (CBD) for pain, anxiety, PTSD, seizures, and more, the concern for potential drug interactions is both reasonable and prudent. Consumers often consider natural substances to be safer than pharmaceuticals, and while this may often be true, it is important for consumers and healthcare providers (HCPs) alike to familiarize themselves with the possible interactions that can occur when CBD is mixed with common medications.

Studies of CBD inhibition and induction of major CYP450...

Read more
Cannabis
By Christopher Shade, PhD

Thealing powers of Cannabis have been utilized by humans since time immemorial, with references to its therapeutic use found in Egyptian scrolls dating back to 1700 BC and Chinese tombs from 550 BC.1,2 Over the past century, Cannabis has experienced a resurgence of interest in the scientific community, with numerous studies confirming its healing properties. Cannabis phytochemicals, including phytocannabinoids and terpenoids, offer tremendous health benefits to your patients by naturally shifting the activity of critical bioregulatory pathways...

Read more
Hemp, Cannabis
By Christopher Shade, PhD
January 25, 2018

Of all the healing botanicals that adorn our planet, few offer the astonishing phytochemical bounty of cannabis. This flowering plant contains a cornucopia of 400 unique chemicals, with approximately 70 non-psychogenic but potent bioactive cannabinoids.1,2 These non-psychogenic cannabinoids are amazingly versatile. Breakthrough research shows cannabinoids may treat everything from opiate addiction to epilepsy, the pain of arthritis and fibromyalgia, and even enhance the efficacy of mainstream treatments for cancer.3-5

Humans discovered the healing and balancing...

Read more
Cannabis
By Nancy Gahles, DC, CCH, RSHom(NA), OIM

New York State finally got on board with offering another alternative to the chronic pain dilemma. Chronic pain is now a qualifying condition for the New York State medical cannabis program. New York’s program1 began in 2016 and has been grossly underutilized largely due to the glaring omission of one of the most prevalent conditions, chronic pain.

When the program was first announced, optimism loomed large as initial estimates for the number of people who would benefit from the program were somewhere between 200,000 and 400,000. To date only 15,000 patients and 911...

Read more